4//SEC Filing
Jayne David R.W. 4
Accession 0001628280-22-015031
CIK 0001600620other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:08 PM ET
Size
7.4 KB
Accession
0001628280-22-015031
Insider Transaction Report
Form 4
Jayne David R.W.
Director
Transactions
- Award
Restricted Stock Unit
2022-05-18+8,733→ 8,733 total→ Common Shares (8,733 underlying) - Award
Stock Option (right to buy)
2022-05-18+14,612→ 14,612 totalExercise: $11.45Exp: 2032-05-18→ Common Stock (14,612 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.
- [F2]The option vests in twelve equal monthly installments commencing on June 18, 2022.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001838242
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:08 PM ET
- Size
- 7.4 KB